Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

ASTRAZENECA : Buy rating from Morgan Stanley

09/17/2021 | 07:11am EDT

In his latest research note, analyst Mark Purcell confirms his positive recommendation. The broker Morgan Stanley is keeping its Buy rating. The target price differs slightly and is now set at GBX 10000 versus GBX 9800.


ę MarketScreener with dpa-AFX Analyser 2021
All news about ASTRAZENECA PLC
10/15ASTRAZENECA : U.S. will accept mixed doses of vaccines from international travelers
RE
10/15ASTRAZENECA : Imfinzi plus tremelimumab significantly improved overall survival in HIMALAY..
PU
10/15GT CAPITAL : Donates 3,000 COVID-19 Vaccine Doses to Government of Makati, Philippines
MT
10/15ASTRAZENECA : JP Morgan remains its Buy rating
MD
10/15AstraZeneca Says Study in Liver Cancer Meets Objective
DJ
10/15ASTRAZENECA : UBS remains its Buy rating
MD
10/15ASTRAZENECA : Says Phase 3 Trial of Potential Imfinzi-Tremelimumab Combination Therapy Mee..
MT
10/15ASTRAZENECA : Japan to Donate Almost 2 Million AstraZeneca COVID-19 Shots to Philippines
MT
10/15CSL : Reaffirms Commitment to Manufacture 50 Million Doses of AstraZeneca Vaccine
MT
10/15ASTRAZENECA : Liver Cancer Combo Therapy Improves Patient Survival in Late-Stage Study
MT
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 35 590 M - -
Net income 2021 4 919 M - -
Net Debt 2021 24 667 M - -
P/E ratio 2021 34,5x
Yield 2021 2,33%
Capitalization 187 B 187 B -
EV / Sales 2021 5,96x
EV / Sales 2022 4,84x
Nbr of Employees 76 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | AZN | GB0009895292 | MarketScreener
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 120,92 $
Average target price 138,73 $
Spread / Average Target 14,7%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC20.08%187 492
JOHNSON & JOHNSON2.49%424 619
ROCHE HOLDING AG16.59%339 442
NOVO NORDISK A/S54.22%234 792
PFIZER, INC.13.20%232 621
ELI LILLY AND COMPANY40.89%215 657